DAWES KAREN A 4
4 · Vaccitech plc · Filed May 12, 2023
Insider Transaction Report
Form 4
Vaccitech plcVACC
DAWES KAREN A
Director
Transactions
- Award
Share Option (Right to Buy)
2023-05-11+19,197→ 19,197 totalExercise: $2.27Exp: 2033-05-11→ Ordinary Shares (19,197 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.